SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001346302-21-000036
Filing Date
2021-04-29
Accepted
2021-04-29 16:21:26
Documents
5
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2021proxystatement.htm DEF 14A 446682
2 image21.jpg GRAPHIC 124174
3 pauledicksignature1a.jpg GRAPHIC 37016
4 xersfinalproxycard0011a.jpg GRAPHIC 149489
5 xersfinalproxycard0021a.jpg GRAPHIC 88336
  Complete submission text file 0001346302-21-000036.txt   991474
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38536 | Film No.: 21870973
SIC: 2834 Pharmaceutical Preparations